Theravectys develops a platform for the prevention and treatment of cancers and other infectious diseases and conditions.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Paris
State: Ile-de-France
Zip:
Country: France
Theravectys is a development-stage biotechnology company with a novel vaccine platform that can be applied to the treatment and prevention of a broad range of infectious diseases, cancers, and other diseases and conditions. Their first clinical studies will be in HIV/AIDS, using their lead product, a therapeutic vaccine, which has shown promising efficacy and safety in non-human primates.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2013 | Series D | 1 | $19.9M |
Tethys BioScience Tethys BioScience Tethys BioScience |
9/2012 | Series C | 4 | $9.4M |
Guy PAILLAUD Richard HENNESSY Philippe ODDO John PIETERS Guy PAILLAUD Richard HENNESSY Philippe ODDO John PIETERS |
2/2021 | Venture Round | $19.9M | 1/2015 | Grant | 1 | $2.1M |
Bpifrance Bpifrance |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|